Emerged! Professional Intermediate Study Coordinator Training Workshop

Similar documents
Clinical Forum Attendee Sample Job Titles

the SPD company Dr Clive Simon, Principal, The SPD Company.

LSIF Convenor s Summary Report to CTI

Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in

WING TAI HOLDINGS DIRECTORS: NEW APPOINTMENTS & RETIREMENT

HOTELS, TOURISM & LEISURE. Hotels, Tourism & Leisure

Board of Directors. Michael George William Barclay. Independent Director. Tsang Yam Pui Chairman and Non-Executive Director

International Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA

CURRICULUM VITAE of ANTHONY HOUGHTON S.C.

Enpr EMA. Enpr-EMA. European Network of Paediatric Research at the European Medicines Agency

Board Composition. The Board line-up: Mr. Terence Kent Cuddyre Independent Non-Executive Director/Chairman

Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective

DIRECTORS, SENIOR MANAGEMENT AND STAFF

Michael George William Barclay Independent Director Member, Audit and Risk Committee

Antitrust & Competition

APFCB- Becton Dickinson Distinguished Service Award 2010

Vice President, Regulatory Affairs, Clinical Research, and Quality Assurance AREAS OF EXPERTISE

CORPORATE PROFILE.

Quality and GLP for Histology and Pathology of Drug Safety Studies

TEMASEK FOUNDATION ASIA URBAN GOVERNANCE LEADERS FORUM 2017

NIHR / Wellcome Trust King s Clinical Research Facility. Guidance for Investigators

BOARD OF DIRECTORS. 6. dato mohammed bin haji Che hussein Independent Director (with effect from 1 January 2009) 10. mr olivier lim Tse ghow Director

J. Lawrence Stevens, RAC 833 E. Rosedale Dr. East Alton, IL (office) (mobile)

ASEAN s LEADING LAB EXHIBITION OCTOBER 2017

Innovative Healing Care

Global Scenario and Medical Device Industry in Malaysia

Presentation. March 2007

Tianjin Onehealth Medical Instruments. Onehealth Your surgical solutions partner

New Approaches to Safety and Risk Management

Tel: Mobile:

Exclusive. InterContinental Shanghai, Expo Pudong New District, Shanghai Thursday October 27, 2016

APPOINTMENT AND RETIREMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND NON-EXECUTIVE DIRECTORS

MARITIME MANAGEMENT MASTER S DEGREE (ONLINE) Train for a leading role in maritime-based organizations.

PROGRAM BIOPHARMACEUTICAL SECTOR

CER-ASEAN Integration Partnership Forum. CER-ASEAN participation in global frameworks for international recognition and harmonisation of measurement

Second APEC Ministers' Conference on Regional Science & Technology Cooperation (Seoul, Korea, Nov 13-14, 1996) JOINT COMMUNIQUÉ

Issues in Emerging Health Technologies Bulletin Process

Nihon M&A Center Inc. Corporate Profile

September 27, 2016, Priora Business Center, Kloten Zurich Airport / Switzerland

ANDREW N. TINSETH Assistant Professor of Clinical Accounting

U.S. Department of Treasury / USAID. Sustaining and Accelerating the Growth of Renewable Energy Markets in Southeast Asia: Lessons from the Field

Green Energy Finance Workshop Monday, 5 June 2017, 9:00 a.m. - 12:30 p.m. 6 ADB Avenue, Mandaluyong City 1550, Metro Manila, Philippines

Health & Social Care Industrial Innovation

Nationality : Malaysia

Maybank wins Best Trade Finance Bank and Leading Counterparty Bank in Malaysia for 2012

RESEARCH DATA MANAGEMENT PROCEDURES 2015

CANDIDATES FOR ELECTION TO THE 2018 COUNCIL

Towards malaria elimination: ADB-supported work at Myanmar FDA

SENIOR MANAGEMENT BILLY URUDRA

The Board is comprised of five members, three of whom are independent directors i.e. Mr Tan Cheng Han, Ms Ooi Chee Kar and Mr Rolf Gerber.

SINGAPORE TO PARTNER THE GOVERNMENT OF SRI LANKA TO DEVELOP CAPABILITY IN URBAN PLANNING AND GOVERNANCE

Intellectual Property, Vaccine Production and Technology Transfer

Update on Progress Implementing the LSIF Anti- Counterfeit Medicines Action Plan

Board of Directors. 1. Tan Sri Dato Dr. Abu Bakar bin Suleiman 2. Dato Dr. Mohamad Hashim bin Ahmad Tajudin

EUROPE March Brussels, Belgium CALL FOR ABSTRACTS. Join Us at the Crossroads of Healthcare. DIAglobal.org/Europe2020 #DIAEurope2020

REITAS Professional Development Series WEDNESDAY 31 OCTOBER 2018 & FRIDAY 2 NOVEMBER 2018 SUNTEC CONVENTION CENTRE

MAH Responsibilities including the Management of CMOs. QP Forum Workshop. Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals

Fortis to acquire strategic stake in Parkway Holdings, Singapore

FDM Asia-Pacific & Australia Graduate Programme

A stringent three-month evaluation process based on a balanced and transparent scorecard had been used to determine the winners.

Workshop on. Evolving the Regulatory Review Process What are the features which enable a transparent, timely, predictable and good quality review?

How Paediatric Research Networks can help drug development

Annual Benefit-Risk Workshop

INDIAN SOCIETY FOR CLINICAL RESEARCH

He has no affiliations with the members of the Board of Commissioners or the Board of Directors, nor with the Shareholders of the Company.

Speakers Profile. LINNET LEE Chief Executive Officer, Financial Planning Association of Malaysia

Group Senior Management

Marlene A. Casini is a Chartered Advisor in Philanthropy (CAP). She joined the Foundation in 2005 from Cleveland where she served as an executive for

Leader in Pharmaceutical Films

Full Legal Entity Name Global LEI Date of renewal

The Product Journey. An insight into Design, Sterilisation, Testing, Clinical Trial and Accreditation

NIHR ROADSHOW FOR MEDTECH SMES

Dammika Peiris, Senior Pharmacovigilance Manager and Head of Chugai Pharma Europe

Action Plan for the Internationalization of the

Human Biological Material Collection, Storage and Use

The Fourth Asia Partnership Conference of Pharmaceutical Associations

Workshop on Advanced Good Clinical Practices (GCP) for Officers of Central & State Drugs Control Organization 12 th -14 th March, 2014

OUR SERVICES CONSULTING

ASEAN Regulatory Harmonisation and Approval Process

Pinsent Masons in Asia Pacific

PENANG THE SILICON ISLAND OF ASIA. DATO SERI LEE KAH CHOON Director of investpenang

Intellectual Property, Technology Transfer and Commercialization

Healthcare and Life Sciences

Confidence Building in Peaceful Use of Nuclear Energy Transparency and Human Resource Development in Asia Pacific Region

Role of SMEs in the Transportation Infrastructure Development

KNOWLEDGE MANAGEMENT. IAEA Program and Activities on NKM. Keiko Hanamitsu, Nuclear Knowledge Management Section Department of Nuclear Energy, IAEA

Current Status and Challenges of Bilateral/Multilateral Meetings

Friday, April 1, :30 a.m. - 4:00 p.m.

Pacific Star Development s CEO named 2017 Malaysia Real Estate Personality of the Year

Jean W. Frydman Partner

The 21 st APEC Small and Medium Enterprises Ministerial Meeting Joint Ministerial Statement. Nanjing, China September 5, 2014

Biocommercialization: Providing Enabling Policy Environments

Virtual Clinical Trials: Challenges and Opportunities

Enhancing Audit Quality and Transparency Supplement Additional information required by Article 13 of EU Regulation 537/2014

DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

Our Leadership Team. Ed Peter, Chairman

Change Announcement of Appointment::Announcement of Appointment of Mr Tan Beng Hai as Director

Probir Das. Managing Director Terumo India Pvt. Ltd

NZFSA Policy on Food Safety Equivalence:

Career Pathways Talk - 28 July 2016 (Thursday) 2015 ISCA

Transcription:

Emerged! Professional Intermediate Study Coordinator Training Workshop Speaker Profile Topic in Emerged! workshop Dr Cheong Yuet Meng President, Society of Clinical Research Professionals Malaysia (SCRPM) Clinical advisor, SunMed Clinical Research Centre Presently she is the Associate Professor of Medical Microbiology and Clinical Investigation Unit, Jeffrey Cheah School of Medicine & Health Sciences and Clinical Advisor to SunMed Clinical Research Centre, Sunway Medical Centre. In March 2011, she was elected the President of the Society of Clinical Research Professionals, Malaysia (SCRPM) formally known as the Association of Clinical Research Professionals, Malaysia (ACRPM). Dr. Cheong started her career with the Ministry of Health, Malaysia at the Institute for Medical Research. Her main areas of research were in Clinical Microbiology & Antibiotic Resistance and she has published over 60 papers in peer review journals. She was also the Dean of the IMR Postgraduate Diploma in Medical Microbiology from 1990-94, that was held annually under the aegis of the South East Asia Ministers of Education & Tropical Medicine Program. In 1994, she joined Pfizer, a leading Pharmaceutical R&D Company, initially as the Medical Director of Pfizer Malaysia/Singapore/Brunei and was later promoted to be the Regional Director of Clinical Operations for Asia. During her 13 years in the pharmaceutical industry she has developed and introduced a number of Clinical Trials to Asia. She is well versed in the operational, regulatory and ethical aspects of conducting clinical trials in various therapeutic areas and is actively involved in the training of investigators in Good Clinical Practice (GCP). After she retired from Pfizer, she continued her work in Clinical Research in Monash University Sunway Campus and has received 2 Pro-Vice Chancellor Awards for Excellence, one for organising the first GCP workshop in Monash and another for setting up a Clinical Research Unit at the Medical School. She is GCP refresher Clinical pathway of Study Coordinator

Dr Yim Poh Yin Member, Joint Penang Independent Ethics Committee (JPEC) Medical monitor (contract), Gleneagles CRC (Pte) Ltd, Singapore Ms Jenny Tan also instrumental in the setting up of the SunMed CRC and the Sunway Medical Centre Independent Research Ethics Committee (SREC). Dr Yim has been involved in clinical trials at various levels since 1998. Presently, she conducst ethical review of clinical trials as a member of the Joint Penang Independent Ethics Committee, which is set up jointly by Penang Medical College and Info Kinetcs and also work in pharmacovigilance as a contract Medical Monitor for selected Phase 2 clinical trials in Gleneagles CRC (Pte) Ltd., Singapore. As early as 1998, she worked with Pfizer as a product physician and managed Phase 2 and 3 clinical trials. As a member of the pharmacovigilance team in Pfizer, she also oversaw reporting of adverse events in clinical trials. Later, she joined the Info Kinetics (a Penangbased research management organization) (2001-2007) as medical manager and research physician. As the research physician, she oversaw the clinical aspects of the Phase 2-3 clinical and bioequivalence trials as well as acted as a co-researcher in some of these trials. From this point forward up till now, she was a regular trainer in the Ministry of Health Malaysia Good Clinical Practice (GCP) certification courses. She has also been an invited speaker in Research Ethics Conferences in Singapore and Malaysia. As an active member in the clinical research industry, she has organized GCP workshops in Penang training local researcher teams. When she later joined the Penang Medical College (2007-2008), she was involv in a few diabetes drug trials as a co-researcher and Project Manager for the National Malaysian Metabolic Syndrome Epidemiology Study 2007. Ms Jenny s present role is a clinical quality lead for Asia region with Pfizer. Her main responsibilities are to promote quality Ethical aspects of clinical trial Revisiting informed consent QC & QA aspects of Clinical Trial

Mr Muraliydharann Regional Operations Director (Asia Pacific) PDP couriers management compliance, inspection readiness, process improvements and oversight needed to ensure high quality performance of country clinical operations in Asia, and these countries include China, Hong Kong, Taiwan, India, Pakistan, Thailand, Philippines, Indonesia and Malaysia/Singapore. She started her career as a registered nurse and later became a clinical instructor in the operating theatre in Malaysia. In the year of 1997, she joined Pfizer as a regional Clinical Research Associate for region Malaysia/Singapore. From Dec 1997 to Jan 2005, she managed trials in various therapeutic areas from pre-trial assessment to study close-out including regulatory submission and budgeting. Throughout these 7 years, she has acquired different position and has engaged into managing AE/SAEs reporting Pfizer s safety system and regulatory authority and also has had some regulatory experience in managing product renewal between years 2001-2002 in Malaysia. With her substantial experiences in the clinical research industry, she was promoted to be the Quality Standards & Process Implementation Manager for Malaysia/Singapore in the year 2005. At that time, she was responsible to drive quality & process improvements in the country office through audit &inspection readiness activities and support and also provide training on SOP/process, new hires and conduct CRAs workshops. One of the key achievements of Ms Jenny was that she has received Pfizer s Charlie award in year 2007 for her contribution to the CRA certification program. Mr Muraliy has had more than 15 years of working experience in the life science logistics industry. He has been working for established Multi National Companies, namely World Courier, Marken and is currently working with PDP Couriers. With his exposure and experience in the Laboratory and Bio-samples packing & shipment

Ms Anna Lee Clinical Study Manager Info Kinetics Sdn Bhd logistics industry, he has in-depth knowledge in managing, operations and provides cold chain solutions and he was instrumental in developing cold chain infrastructural and network capabilities across Asia Pacific Region for the companies that he has been working with. He is a specialist in handling all types of dangerous goods shipments and he also provides training in operations, cold chain shipments handling, handling in clinical trials. Mr Muraliy has spear headed in operational set up in Asia Pacific Region for current and previous employment. He had vast experience in advising in the provision of packaging with respect to samples shipping and also having full knowledge and experience in handling and shipping Pharmaceutical products in Envirotainer, Enviro-Cooler, etc;. With his expertise and substantial past experiences, he make an expert advisor in operations, logistics and Government regulatory requirements for various countries across Asia Pacific Region in clinical trials, samples shipping. Ms Anna joined Info Kinetics as a study coordinator in the year of 2007 and later promoted to clinical study manager in the year of 2010. She has managed and coordinated more than 20 clinical trials in the past and still counting. During her role as a study coordinator, she has acquired substantial experiences in coordinating site operations and clinical protocol execution. She has developed and implemented various standard operating procedures with various participating sites for smooth clinical research operations and ensures site GCP compliance. She also involved in clinical trial agreement and site budget review. With her experience in the clinical research industry, she also conducts protocol review and site feasibility review and provides expertise advice in Investigator product/study drug management Source documentation/ CRF Record keeping & retention Archival process Safety assessment, AE/ConMed documentation

Ms Patricia Khoo Senior Study Coordinator Info Kinetics Sdn Bhd clinical study management. With her substantial exposure in this industry, she has helped in setting up clinical trial site that meets industry and regulatory standards. Presently, she is overseeing all clinical operations that are being conducted at 5 institutions in Penang. She had developed study coordinator manual internally for inhouse training and has been speaker for Emerged! Professional Intermediate Study Coordinator Training workshop last year and BeST program (jointly organized by PSDC Penang and Biotechcorp) Ms Patricia graduated with a major in drug design and development from the university of Queensland. She joint Info Kinetics as a study coordinator in the year of 2009. She is currently coordinating more than 6 studies at 4 institutions. She has in-depth experiences in all aspects of the roles and responsibilities of study coordinator and sponsor audit. Presently, she is also conducting pre-study assessment and be the liaison between sponsor/cro and all hospitals in Penang for feasibility study. She is also heading the recruitment team for patient recruitment and education program. She is also a PSMB certified trainer in designing and delivering competency-based training program. She also has experience in providing study coordinator training internally and externally. She has been speaker and facilitator for Emerged! Professional Intermediate Study Coordinator training workshop 2010. Drug Design & Development Know our industry player Planning & Execution of protocol PSV/SIV Tips to be a good SC